To include your compound in the COVID-19 Resource Center, submit it here.

Erbitux cetuximab: Phase III data

Top-line data from the open-label, Chinese Phase III TAILOR trial in 397 patients with wild-type Ras mCRC showed that first-line treatment

Read the full 217 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE